Kagdi, H., Fields, P., Hodson, A., & Taylor, G. (2014). Case reports: Combination therapy with proteasome inhibitor Bortezomib and humanized anti-CD25 Basiliximab for treatment of adult T cell leukaemia lymphoma. BioMed Central.
Citação norma ChicagoKagdi, Huseini, Paul Fields, Andrew Hodson, and Graham Taylor. Case Reports: Combination Therapy With Proteasome Inhibitor Bortezomib and Humanized Anti-CD25 Basiliximab for Treatment of Adult T Cell Leukaemia Lymphoma. BioMed Central, 2014.
MLA CitationKagdi, Huseini, Paul Fields, Andrew Hodson, and Graham Taylor. Case Reports: Combination Therapy With Proteasome Inhibitor Bortezomib and Humanized Anti-CD25 Basiliximab for Treatment of Adult T Cell Leukaemia Lymphoma. BioMed Central, 2014.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.